Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Current Taxes (2020 - 2025)

Legend Biotech filings provide 6 years of Current Taxes readings, the most recent being $19.2 million for Q4 2025.

  • On a quarterly basis, Current Taxes fell 7.25% to $19.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.2 million, a 7.25% decrease, with the full-year FY2025 number at $19.2 million, down 7.25% from a year prior.
  • Current Taxes hit $19.2 million in Q4 2025 for Legend Biotech, up from $10.1 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $20.7 million in Q4 2024 to a low of $6.6 million in Q2 2024.
  • Median Current Taxes over the past 5 years was $9.9 million (2023), compared with a mean of $11.1 million.
  • The widest YoY moves for Current Taxes: up 187.38% in 2024, down 36.41% in 2024.
  • Legend Biotech's Current Taxes stood at $9.5 million in 2021, then increased by 2.99% to $9.8 million in 2022, then decreased by 26.29% to $7.2 million in 2023, then skyrocketed by 187.38% to $20.7 million in 2024, then dropped by 7.25% to $19.2 million in 2025.
  • The last three reported values for Current Taxes were $19.2 million (Q4 2025), $10.1 million (Q3 2025), and $11.5 million (Q2 2025) per Business Quant data.